doi:10.3969/j.issn.1004-583X.2024.07.012

Abstract

CLC Number:

R587.1

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2024.07.012

https://huicui.hebmu.edu.cn/EN/Y2024/V39/I7/650

References 25

[1]	Aschner P, Karuranga S, James S, et al. The international diabetes federation’s guide for diabetes epidemiological studies[J]. Diabetes Res Clin Pract, 2021, 172:108630.
[2]	NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants[J]. Lancet, 2016, 387(10027): 1513-1530.
[3]	Magliano DJ, Boyko EJ, IDF diabetes atlas 10th edition scientific committee. IDF Diabetes Atlas[R]. 10th ed. Brussels: International Diabetes Federation, 2021.
[4]	World Health Organization. Classification of diabetes mellitus 2019[R]. Gevena: World Health Organization, 2019.
[5]	ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of diabetes: Standards of care in diabetes-2023[J]. Diabetes care, 2023, 46(Suppl 1): S19-S40.
[6]	Himsorth HP. Diabetes mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types. 1936[J]. Int J Epidemiol, 2013, 42(6): 1594-1598. doi: 10.1093/ije/dyt203 pmid: 24415598
[7]	孙颖, 邵丹青. 成人糖尿病分型及健康管理应用[J]. 慢性病学杂志, 2023, 24(2): 214-219.
[8]	Gorden P. Non-insulin dependent diabetes--the past, present and future[J]. Ann Acad Med Singap, 1997, 26(3): 326-330. pmid: 9285027
[9]	王继伟, 徐望红, 王继伟.等. 我国慢性病防治成功案例——中国大庆糖尿病预防研究的分析及启示[J]. 中华内分泌代谢杂志, 2013,29(3):196-199
[10]	Eriksson J, Lindström J, Valle T, et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: The Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme[J]. Diabetologia, 1999, 42(7): 793-801. pmid: 10440120
[11]	Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin[J]. N Engl J Med, 2002, 346(6): 393-403.
[12]	Alberti KG, Zimmet PZ. efinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553.
[13]	Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables[J]. Lancet Diabetes Endocrinol, 2018, 6(5): 361-369.
[14]	裴晓蓓. 成人糖尿病国际新分型及其对临床用药的指导分析[J]. 临床合理用药杂志, 2019, 12(14): 169-170.
[15]	Dennis JM, Shield BM, Henley WE, et al. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: An analysis using clinical trial data[J]. Lancet Diabetes Endocrinol, 2019, 7(6): 442-451.
[16]	Zou X, Zhou X, Zhu Z, et al. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations[J]. Lancet Diabetes Endocrinol, 2019, 7(1): 9-11.
[17]	潘锋. 聚类分型有利于实现糖尿病精准管理和治疗——访北京大学人民医院内分泌科主任纪立农教授[J]. 中国当代医药, 2019, 26(19): 1-3.
[18]	Li X, Yang S, Cao C, et al. Validation of the swedish diabetes re-grouping scheme in adult-onset diabetes in China[J]. J Clin Endocrinol Metab, 2020, 105(10):dgaa524.
[19]	Zaharia OP, Strassburger K, Strom A, et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: A 5-year follow-up study[J]. Lancet Diabetes Endocrinol, 2019, 7(9): 684-694.
[20]	Tanabe H, Saito H, Kudo A, et al. Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: A Japanese retrospective cohort study[J]. J Clin Med, 2020, 9(7):2083.
[21]	Safai N, Ali A, Rossing P, et al. Stratification of type 2 diabetes based on routine clinical markers[J]. Diabetes Res Clin Pract, 2018, 141: 275-283.
[22]	Segar MW, Patel KV, Vaduganathan M, et al. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes[J]. Diabetologia, 2021, 64(7): 1583-1594. doi: 10.1007/s00125-021-05426-2 pmid: 33715025
[23]	中国医师协会内分泌代谢科医师分会, 国家代谢性疾病临床医学研究中心. 糖尿病分型诊断中国专家共识[J]. 中华糖尿病杂志, 2022, 14(2):120-139.
[24]	Guo Y, Zhao X, Liu CQ, et al. A novel refined classification system for type 2 diabetes in adults: A Chinese retrospective cohort study[J]. Diabetes Metab Res Rev, 2022, 38(8): e3577.
[25]	Huang Y, Wang Y, Liu C, et al. C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real-world study[J]. Diabetes Metab Res Rev, 2022, 38(4): e3514.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 25

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yue Jianghong, Wang Heng, Cai Gang, Zhang Xuanming, Peng Xi. Efficacy and safety of sotagliflozin in the treatment of type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2024, 39(7): 581-592.
[2]	Du Sina, Li Wei, Lin Yajing, Sun Jianguo, Mao Mao, Chen Jianwei, Sun Danbo, Mao Yushan. Application of insulin dose spectrum after an intensive insulin pump therapy in type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(7): 620-624.
[3]	Sun Hui, Liu Haiying, Ren Junhao, Li Jinxia. Bidirectional Mendelian randomization study of causality between body mass index and type 2 diabetes in a European population [J]. Clinical Focus, 2024, 39(4): 325-331.
[4]	. [J]. Clinical Focus, 2024, 39(3): 274-278.
[5]	Lv Shasha, Song Jinlan, Shi Jian. Mitochondrial mutation m.3243A> G associated with diabetes mellitus: One case report and literature review [J]. Clinical Focus, 2024, 39(2): 160-163.
[6]	Zhang Jianan, Sun Linlin, Zhan Xiaoyan, Li Bing. Correlation between serum Vitamin B₁₂ and mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(1): 34-37.
[7]	Liao Kunfeng, Yao Yisong, Yang Jinpan, Yang Xining, Li Yaru, Zhou Hongyan, Liang Piao. Status and influencing factors of fear of progression in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(12): 1095-1100.
[8]	Shi Peihua, Lin Yanlin, Bi Lifang. Study on the correlation of NLR, PLR and MLR with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2023, 38(11): 996-1001.
[9]	Yang Xin, Xu Huajiao. Bibliometric analysis of literatures reporting psychological intervention of patients with diabetes mellitus: Based on Web of Science [J]. Clinical Focus, 2023, 38(8): 731-736.
[10]	Jin Jiahui, Yang Yang, Qin Tong, He Yuxin, Su Meihua. Probiotic supplementation on improving glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(7): 581-587.
[11]	Wu Yanan, Yan Tianmei, Liang Peng, Wei Limin. High-risk identification of depressive symptoms in middle-elderly patients with diabetes [J]. Clinical Focus, 2023, 38(6): 516-520.
[12]	Yang Minxing, Sun Lu, Ye Yun, Xu Wendong, Huang Xiaolin, Zhang Haiyun, Xu Yinglei. Characteristics of cognitive function and corresponding factors in young and middle-aged patients with type 2 diabetes with obstructive sleep apnea hypopnea syndrome [J]. Clinical Focus, 2023, 38(3): 216-220.
[13]	Rao Xiaojuan, Shi Shuangwei, Sang Yanhong. Comparison of short-term efficacy of insulin degludec/insulin versus continuous subcutaneous infusion of insulin asparton diabetic patients admitted in non-endocrinology departments [J]. Clinical Focus, 2023, 38(2): 132-136.
[14]	Xie Feifei, Zhang Weijian. Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(1): 20-36.
[15]	Wang Cui, Lin Hao, Wu Pingping, Zhang Yali, Ren Jian, Xu Ting, Dong Guoyu, Zai Guotian. Correlation between hyperhomocysteinemia and early renal disease in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 42-45.